search
Back to results

Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional. (P-HEARTNER)

Primary Purpose

Myocardial Infarction

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership
Teleconsultation at 2 months
Teleconsultation at 4 months
Remote group education workshop
Administration of self-questionnaires: IPAQ, EMAPS, the Exercise Confidence Survey, EQ-5D-5L and the Mediterranean diet adherence score.
6-minute walk test and administers the modified Borg scale at its conclusion.
Biological check-up
Accelerometer
Administration of a logbook
Sponsored by
Centre Hospitalier Universitaire de Nīmes
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Myocardial Infarction focused on measuring Cardiovascular Rehabilitation, Motivation, Physical Activity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Patient of legal age (≥ 18 years). Patient having undergone phase 2 treatment in the cardiovascular rehabilitation department of the CHU for myocardial infarction. Patient with a means of communication that allows easy internet connection (i.e. a smartphone). Patient fluent in French. Patient who has given free informed consent. Patient affiliated or beneficiary of a health insurance scheme. Exclusion Criteria: Patient with severe or unstable comorbidity (respiratory insufficiency renal failure, decompensated heart failure). heart failure). Patient with unstable angina. Patient with contraindications to physical activity following physical activity following cardiovascular rehabilitation (according to medical discussion, based on the recommendations of the French Society of Cardiology). Patient with no suitable means of communication. Patient under court protection, guardianship or curatorship. Pregnant, parturient or breast-feeding patients.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    Controls

    Experimental Group

    Arm Description

    Patients in Phase 3 of cardiac rehabilitation, undergoing the usual care provided.

    Patients in Phase 3 of cardiovascular rehabilitation, following a therapeutic educational program for consolidation ("patient partner" and a caregiver) as well as the usual care provided.

    Outcomes

    Primary Outcome Measures

    Moderate-to-sustained physical activity in the Experimental Group
    The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (> 3 METs) will be measured in minutes per week.
    Moderate-to-sustained physical activity in Controls
    The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (> 3 METs) will be measured in minutes per week.

    Secondary Outcome Measures

    Moderate-to-sustained physical activity in the Experimental Group
    The amount of moderate-to-sustained physical activity (> 3 METs) will be measured with the accelerometer in minutes per week.
    Moderate-to-sustained physical activity in Controls
    The amount of moderate-to-sustained physical activity (> 3 METs) will be measured with the accelerometer in minutes per week.
    Number of steps taken per week in the Experimental Group
    Number of steps taken per week recorded by the accelerometer
    Number of steps taken per week in the Experimental Group
    Number of steps taken per week recorded by the accelerometer
    Number of steps taken per week in the Experimental Group
    Number of steps taken per week recorded by the accelerometer
    Number of steps taken per week in Controls
    Number of steps taken per week recorded by the accelerometer
    Number of steps taken per week in Controls
    Number of steps taken per week recorded by the accelerometer
    Number of steps taken per week in Controls
    Number of steps taken per week recorded by the accelerometer
    Time spent sitting/lying down per week in the Experimental Group
    Time spent sitting/lying down per week recorded by the accelerometer
    Time spent sitting/lying down per week in the Experimental Group
    Time spent sitting/lying down per week recorded by the accelerometer
    Time spent sitting/lying down per week in the Experimental Group
    Time spent sitting/lying down per week recorded by the accelerometer
    Time spent sitting/lying down per week in Controls
    Time spent sitting/lying down per week recorded by the accelerometer
    Time spent sitting/lying down per week in Controls
    Time spent sitting/lying down per week recorded by the accelerometer
    Time spent sitting/lying down per week in Controls
    Time spent sitting/lying down per week recorded by the accelerometer
    International Physical Activity Questionnaire Score in the Experimental Group
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    International Physical Activity Questionnaire Score in the Experimental Group
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    International Physical Activity Questionnaire Score in the Experimental Group
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    International Physical Activity Questionnaire Score in Controls
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    International Physical Activity Questionnaire Score in Controls
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    International Physical Activity Questionnaire Score in Controls
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Blood pressure in the Experimental Group
    mm Hg
    Blood pressure in the Experimental Group
    mm Hg
    Blood pressure in the Experimental Group
    mm Hg
    Blood pressure in Controls
    mm Hg
    Blood pressure in Controls
    mm Hg
    Blood pressure in Controls
    mm Hg
    Modified Borg score in the Experimental Group
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Modified Borg score in the Experimental Group
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Modified Borg score in the Experimental Group
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Modified Borg score in Controls
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Modified Borg score in Controls
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Modified Borg score in Controls
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Abdominal circumference in the Experimental Group
    In cm
    Abdominal circumference in the Experimental Group
    In cm
    Abdominal circumference in the Experimental Group
    In cm
    Abdominal circumference in Controls
    In cm
    Abdominal circumference in Controls
    In cm
    Abdominal circumference in Controls
    In cm
    Aerobic capacity in the Experimental Group
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Aerobic capacity in the Experimental Group
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Aerobic capacity in the Experimental Group
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Aerobic capacity in Controls
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Aerobic capacity in Controls
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Aerobic capacity in Controls
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Cholesterol in the Experimental Group
    mg/dL
    Cholesterol in the Experimental Group
    mg/dL
    Cholesterol in the Experimental Group
    mg/dL
    Cholesterol in Controls
    mg/dL
    Cholesterol in Controls
    mg/dL
    Cholesterol in Controls
    mg/dL
    Low-density lipoprotein in the Experimental Group
    mg/dL
    Low-density lipoprotein in the Experimental Group
    mg/dL
    Low-density lipoprotein in the Experimental Group
    mg/dL
    Low-density lipoprotein in Controls
    mg/dL
    Low-density lipoprotein in Controls
    mg/dL
    Low-density lipoprotein in Controls
    mg/dL
    High-density lipoprotein in the Experimental Group
    mg/dL
    High-density lipoprotein in the Experimental Group
    mg/dL
    High-density lipoprotein in the Experimental Group
    mg/dL
    High-density lipoprotein in Controls
    mg/dL
    High-density lipoprotein in Controls
    mg/dL
    High-density lipoprotein in Controls
    mg/dL
    Triglycerides in the Experimental Group
    mg/dL
    Triglycerides in the Experimental Group
    mg/dL
    Triglycerides in the Experimental Group
    mg/dL
    Triglycerides in Controls
    mg/dL
    Triglycerides in Controls
    mg/dL
    Triglycerides in Controls
    mg/dL
    Blood glucose levels in the Experimental Group
    mg/dL
    Blood glucose levels in the Experimental Group
    mg/dL
    Blood glucose levels in the Experimental Group
    mg/dL
    Blood glucose levels in Controls
    mg/dL
    Blood glucose levels in Controls
    mg/dL
    Blood glucose levels in Controls
    mg/dL
    Compliance with medication in the Experimental Group
    YES/NO
    Compliance with medication in the Experimental Group
    YES/NO
    Compliance with medication in the Experimental Group
    YES/NO
    Compliance with medication in Controls
    YES/NO
    Compliance with medication in Controls
    YES/NO
    Compliance with medication in Controls
    YES/NO
    Motivation for doing physical activity in the Experimental Group
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Motivation for doing physical activity in the Experimental Group
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Motivation for doing physical activity in the Experimental Group
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Motivation for doing physical activity in Controls
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Motivation for doing physical activity in Controls
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Motivation for doing physical activity in Controls
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Exercise Confidence Survey in the Experimental Group
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Exercise Confidence Survey in the Experimental Group
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Exercise Confidence Survey in the Experimental Group
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Exercise Confidence Survey in Controls
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Exercise Confidence Survey in Controls
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Exercise Confidence Survey in Controls
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Mediterranean diet adherence test in the Experimental Group
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Mediterranean diet adherence test in the Experimental Group
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Mediterranean diet adherence test in the Experimental Group
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Mediterranean diet adherence test in Controls
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Mediterranean diet adherence test in Controls
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Mediterranean diet adherence test in Controls
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Understanding barriers to motivation: Experimental group
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Understanding barriers to motivation: Experimental group
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Understanding barriers to motivation: Experimental group
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Understanding barriers to motivation in Controls
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Understanding barriers to motivation in Controls
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Understanding barriers to motivation in Controls
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research

    Full Information

    First Posted
    June 22, 2023
    Last Updated
    June 30, 2023
    Sponsor
    Centre Hospitalier Universitaire de Nīmes
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05927363
    Brief Title
    Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.
    Acronym
    P-HEARTNER
    Official Title
    Impact on the Physical Activity Level of Coronary Patients in Phase 3 of a Therapeutic Educational Consolidation Program Involving a "Patient Partner" Associated With a Healthcare Professional. A Randomized Controlled Trial.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2023
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    October 1, 2023 (Anticipated)
    Primary Completion Date
    October 1, 2025 (Anticipated)
    Study Completion Date
    March 31, 2026 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Centre Hospitalier Universitaire de Nīmes

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Following myocardial infarction, cardiac rehabilitation has undeniable benefits on criteria such as cardiovascular mortality and coronary recurrence. Cardiac rehabilitation consists of 3 phases: immediate post-acute, in a cardiology department, active cardiac rehabilitation for several weeks under medical supervision as an inpatient or outpatient, Resumption of active life by the patient. Indeed, one of the major aims of secondary prevention is long-term adherence to physical activity.However, only 20% to 40% of coronary patients remain physically active at 6 months or 1 year, and the effects of Phase 2 cardiac rehabilitation are not maintained. Managing to maintain at least a moderate level of physical activity after Phase 2 of CR is a major objective. Various interventions (booklets, applications, activity programs, motivational talks led by healthcare professionals have been tested and compared with the usual care in Phase 3 cardiac rehabilitation. An effect seems to exist on the level of physical activity reported, but with a significant evaluation bias. This study aims to use accelerometry to evaluate the 6-month efficacy of the therapeutic education program for consolidation in phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver on moderate-to-sustained physical activity (> 3 METs) in coronary patients on Phase 3 of cardiac rehabilitation compared with usual rehabilitation management.
    Detailed Description
    Following myocardial infarction, cardiac rehabilitation has shown undeniable benefits on strong criteria such as cardiovascular mortality and coronary recurrence. Cardiac rehabilitation consists of 3 phases: immediate post-acute, in a cardiology department, active cardiac rehabilitation for several weeks under medical supervision as an inpatient or outpatient, Resumption of active life by the patient: one of the major aims of secondary prevention is long-term adherence to physical activity. The importance of phase 2 of cardiac rehabilitation is particularly emphasized and is the subject of recommendations by learned societies. The aim is to re-train the patient under paramedical and medical supervision, and to induce behavioral changes through specific therapeutic education. Exercise re-training aims to increase the patient's cardiorespiratory functional capacity and their ability to do physical activity of moderate-to-sustained intensity. One of the most commonly used units to calculate the intensity of physical activity is the Metabolic Equivalent of Task (MET). The higher the intensity of the activity, the higher the number of METs. Physical activity of at least moderate intensity, as recommended in the long-term care of coronary patients corresponds to 3 METs. The therapeutic objective by international recommendations, and explained to patients during phase 2 CR, is to achieve 150 minutes a week of moderate-to-sustained physical activity (3 METs or more). However, only 20% to 40% of coronary patients remain physically active at 6 months or 1 year, which means that the effects of Phase 2 cardiac rehabilitation are not maintained. Managing to maintain at least a moderate level of physical activity after phase 2 of CR, is a major objective. Various interventions (booklets, applications, activity programs, motivational talks led by healthcare professionals have been tested and compared with the usual care in Phase 3 cardiac rehabilitation. An effect seems to exist on the level of physical activity reported, but with a significant evaluation bias. Objective, validated measures of physical activity such as accelerometry have not proved their long-term efficacy (6 months being the classically explored endpoint). An intervention establishing a patient-centered relationship and cognitive-behavioral elements would seem to be a perspective of choice to be explored, therapeutic education having been little explored in phase 3 of cardiac rehabilitation and in the long term. To address some of the barriers identified in qualitative studies, the joint participation of a "patient partner" would seem to of interest. The PP is a patient who has acquired knowledge of their disease over time, through experience and experience and therapeutic education. They encourage dialogue between care teams and patients, facilitating patients' self-expression, and contributes to a better understanding of the discourse. The hypothesis is that a therapeutic educational consolidation program, involving a "patient partner" associated with a health professional, will increase the level of physical activity of coronary patients in Phase 3 of cardiac rehabilitation. The main objective of this study is to use accelerometry to evaluate the 6-month efficacy of the therapeutic education program for consolidation in phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver on the level of moderate to sustained physical activity (> 3 METs) in coronary patients on Phase 3 of cardiac rehabilitation compared with usual rehabilitation management.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Myocardial Infarction
    Keywords
    Cardiovascular Rehabilitation, Motivation, Physical Activity

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    Participant
    Masking Description
    Participants will not know whether they have been randomized to the group receiving the usual, standard rehabilitation or the group following the Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.
    Allocation
    Randomized
    Enrollment
    84 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Controls
    Arm Type
    No Intervention
    Arm Description
    Patients in Phase 3 of cardiac rehabilitation, undergoing the usual care provided.
    Arm Title
    Experimental Group
    Arm Type
    Experimental
    Arm Description
    Patients in Phase 3 of cardiovascular rehabilitation, following a therapeutic educational program for consolidation ("patient partner" and a caregiver) as well as the usual care provided.
    Intervention Type
    Other
    Intervention Name(s)
    Therapeutic educational consolidation program in Phase 3 of cardiac rehabilitation associating a patient & caregiver partnership
    Intervention Description
    In the experimental group, patients benefit from the usual management as part of the phase 2 post-CR follow-up, with the provision of an information booklet on the benefits of physical activity, and a telephone contact in the event of any questions. In addition, they benefit from the "Consolidation therapeutic education program in phase 3 of CR associating a patient & caregiver partnership, which consists of two teleconsultation sessions at 2 and 4 months, followed by a remote group education workshop co-facilitated by the patient and caregiver partnership at 5 months. Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
    Intervention Type
    Other
    Intervention Name(s)
    Teleconsultation at 2 months
    Intervention Description
    Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
    Intervention Type
    Other
    Intervention Name(s)
    Teleconsultation at 4 months
    Intervention Description
    Discussions during teleconsultations will be recorded to identify the main barriers to physical activity mentioned by patients, and the responses provided by the healthcare professional-peer helper pair during the therapeutic education sessions.
    Intervention Type
    Other
    Intervention Name(s)
    Remote group education workshop
    Intervention Description
    This remote workshop will be co-facilitated by the patient and caregiver partnership at 5 months
    Intervention Type
    Other
    Intervention Name(s)
    Administration of self-questionnaires: IPAQ, EMAPS, the Exercise Confidence Survey, EQ-5D-5L and the Mediterranean diet adherence score.
    Intervention Description
    Patients are then randomly assigned to either the control group (usual management) or the experimental group (management with Patient and Caregiver partnership).
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    6-minute walk test and administers the modified Borg scale at its conclusion.
    Intervention Description
    What is a modified Borg scale? The Modified Borg Dyspnea Scale is a 0 to 10 rated numerical score used to measure dyspnea as reported by the patient during submaximal exercise and is routinely administered following a six-minute walking test, one of the most common and frequently used measures to assess disease severity in patients with pulmonary arterial hypertension. Upon conclusion of the 6-minute walking test, the modified Borg scale will be recorded.
    Intervention Type
    Diagnostic Test
    Intervention Name(s)
    Biological check-up
    Intervention Description
    This check-up includes total cholesterol, LDL, HDL, triglycerides, HbA1c.
    Intervention Type
    Device
    Intervention Name(s)
    Accelerometer
    Intervention Description
    An accelerometer is given to the patient, with instructions to wear it for 7 days following the visit (it will then be returned by post).Pre-stamped "bubble" envelopes are given to the patient to return their accelerometer to the measurement points specified in the follow-up.
    Intervention Type
    Other
    Intervention Name(s)
    Administration of a logbook
    Intervention Description
    The patient is given a logbook for daily monitoring of non-measurable physical activities, treatments and medical procedures carried out, as well as any intercurrent events.
    Primary Outcome Measure Information:
    Title
    Moderate-to-sustained physical activity in the Experimental Group
    Description
    The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (> 3 METs) will be measured in minutes per week.
    Time Frame
    Month 6
    Title
    Moderate-to-sustained physical activity in Controls
    Description
    The accelerometer will be used to evaluate the 6-month efficacy of the therapeutic educational program for consolidation in Phase 3 of Cardiovascular Rehabilitation involving a patient partner and a caregiver and its affect on the level of moderate-to-sustained physical activity (> 3 METs) in coronary patients in Phase 3 of cardiac rehabilitation compared with usual rehabilitation management. The amount of moderate-to-sustained physical activity (> 3 METs) will be measured in minutes per week.
    Time Frame
    Month 6
    Secondary Outcome Measure Information:
    Title
    Moderate-to-sustained physical activity in the Experimental Group
    Description
    The amount of moderate-to-sustained physical activity (> 3 METs) will be measured with the accelerometer in minutes per week.
    Time Frame
    Month 3
    Title
    Moderate-to-sustained physical activity in Controls
    Description
    The amount of moderate-to-sustained physical activity (> 3 METs) will be measured with the accelerometer in minutes per week.
    Time Frame
    Month 3
    Title
    Number of steps taken per week in the Experimental Group
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 0
    Title
    Number of steps taken per week in the Experimental Group
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 3
    Title
    Number of steps taken per week in the Experimental Group
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 6
    Title
    Number of steps taken per week in Controls
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 0
    Title
    Number of steps taken per week in Controls
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 3
    Title
    Number of steps taken per week in Controls
    Description
    Number of steps taken per week recorded by the accelerometer
    Time Frame
    Month 6
    Title
    Time spent sitting/lying down per week in the Experimental Group
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 0
    Title
    Time spent sitting/lying down per week in the Experimental Group
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 3
    Title
    Time spent sitting/lying down per week in the Experimental Group
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 6
    Title
    Time spent sitting/lying down per week in Controls
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 0
    Title
    Time spent sitting/lying down per week in Controls
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 3
    Title
    Time spent sitting/lying down per week in Controls
    Description
    Time spent sitting/lying down per week recorded by the accelerometer
    Time Frame
    Month 6
    Title
    International Physical Activity Questionnaire Score in the Experimental Group
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 0
    Title
    International Physical Activity Questionnaire Score in the Experimental Group
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 3
    Title
    International Physical Activity Questionnaire Score in the Experimental Group
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 6
    Title
    International Physical Activity Questionnaire Score in Controls
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 0
    Title
    International Physical Activity Questionnaire Score in Controls
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 3
    Title
    International Physical Activity Questionnaire Score in Controls
    Description
    The short form of the International Physical Activity Questionnaire measures physical activity over the previous week and assesses the types of intensity of physical activity, and sitting time to estimate total physical activity in MET-min/week and time spent sitting. For each category of activity a maximum of 21 hours of activity are permitted a week (3 hours X 7 days).To calculate MET-minutes a week the MET value given (walking = 3.3, moderate activity = 4, vigorous activity = 8) is multiplied by the number of minutes the activity was carried out, and again by the number of days that that activity was undertaken. For example if someone reports walking for 30 minutes 5 days a week then the total MET-minutes for that activity are 3.3 X 30 X 5=495 MET-minutes a week. The MET minutes achieved in each category (walking, moderate activity and vigorous activity) are then added together to get the total MET-minutes of physical activity per week.
    Time Frame
    Month 6
    Title
    Blood pressure in the Experimental Group
    Description
    mm Hg
    Time Frame
    Month 0
    Title
    Blood pressure in the Experimental Group
    Description
    mm Hg
    Time Frame
    Month 3
    Title
    Blood pressure in the Experimental Group
    Description
    mm Hg
    Time Frame
    Month 6
    Title
    Blood pressure in Controls
    Description
    mm Hg
    Time Frame
    Month 0
    Title
    Blood pressure in Controls
    Description
    mm Hg
    Time Frame
    Month 3
    Title
    Blood pressure in Controls
    Description
    mm Hg
    Time Frame
    Month 6
    Title
    Modified Borg score in the Experimental Group
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 0
    Title
    Modified Borg score in the Experimental Group
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 3
    Title
    Modified Borg score in the Experimental Group
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 6
    Title
    Modified Borg score in Controls
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 0
    Title
    Modified Borg score in Controls
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 3
    Title
    Modified Borg score in Controls
    Description
    The modified Borg dyspnea score uses a scale from 0 to 10 in which 0 represents no dyspnea and 10 represents maximal dyspnea. Scores are obtained at the end of the 6-minute walking test and reflect the maximum degree of dyspnea at any time during the walk test.
    Time Frame
    Month 6
    Title
    Abdominal circumference in the Experimental Group
    Description
    In cm
    Time Frame
    Month 0
    Title
    Abdominal circumference in the Experimental Group
    Description
    In cm
    Time Frame
    Month 3
    Title
    Abdominal circumference in the Experimental Group
    Description
    In cm
    Time Frame
    Month 6
    Title
    Abdominal circumference in Controls
    Description
    In cm
    Time Frame
    Month 0
    Title
    Abdominal circumference in Controls
    Description
    In cm
    Time Frame
    Month 3
    Title
    Abdominal circumference in Controls
    Description
    In cm
    Time Frame
    Month 6
    Title
    Aerobic capacity in the Experimental Group
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 0
    Title
    Aerobic capacity in the Experimental Group
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 3
    Title
    Aerobic capacity in the Experimental Group
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 6
    Title
    Aerobic capacity in Controls
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 0
    Title
    Aerobic capacity in Controls
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 3
    Title
    Aerobic capacity in Controls
    Description
    Aerobic capacity clinically measured by the 6-minute walking test (number of metres covered).
    Time Frame
    Month 6
    Title
    Cholesterol in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Cholesterol in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Cholesterol in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Cholesterol in Controls
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Cholesterol in Controls
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Cholesterol in Controls
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Low-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Low-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Low-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Low-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Low-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Low-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    High-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    High-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    High-density lipoprotein in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    High-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    High-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    High-density lipoprotein in Controls
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Triglycerides in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Triglycerides in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Triglycerides in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Triglycerides in Controls
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Triglycerides in Controls
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Triglycerides in Controls
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Blood glucose levels in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Blood glucose levels in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Blood glucose levels in the Experimental Group
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Blood glucose levels in Controls
    Description
    mg/dL
    Time Frame
    Month 0
    Title
    Blood glucose levels in Controls
    Description
    mg/dL
    Time Frame
    Month 3
    Title
    Blood glucose levels in Controls
    Description
    mg/dL
    Time Frame
    Month 6
    Title
    Compliance with medication in the Experimental Group
    Description
    YES/NO
    Time Frame
    Month 0
    Title
    Compliance with medication in the Experimental Group
    Description
    YES/NO
    Time Frame
    Month 3
    Title
    Compliance with medication in the Experimental Group
    Description
    YES/NO
    Time Frame
    Month 6
    Title
    Compliance with medication in Controls
    Description
    YES/NO
    Time Frame
    Month 0
    Title
    Compliance with medication in Controls
    Description
    YES/NO
    Time Frame
    Month 3
    Title
    Compliance with medication in Controls
    Description
    YES/NO
    Time Frame
    Month 6
    Title
    Motivation for doing physical activity in the Experimental Group
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 0
    Title
    Motivation for doing physical activity in the Experimental Group
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 3
    Title
    Motivation for doing physical activity in the Experimental Group
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 6
    Title
    Motivation for doing physical activity in Controls
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 0
    Title
    Motivation for doing physical activity in Controls
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 3
    Title
    Motivation for doing physical activity in Controls
    Description
    The EMAPS scale (Echelle de Motivation envers l'Activité Physique en contexte de Santé = Scale for Motivation for Physical Activity in the Context of Health).This is an 18-item questionnaire with scores from 1 to 7. Depending on the patient's answers to the questions, the type and extent of motivation are defined. Score 18 - 126
    Time Frame
    Month 6
    Title
    Exercise Confidence Survey in the Experimental Group
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 0
    Title
    Exercise Confidence Survey in the Experimental Group
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 3
    Title
    Exercise Confidence Survey in the Experimental Group
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 6
    Title
    Exercise Confidence Survey in Controls
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 0
    Title
    Exercise Confidence Survey in Controls
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 3
    Title
    Exercise Confidence Survey in Controls
    Description
    French version of the "Exercise Confidence Survey" for regular physical activity) according to Eeckhout et al. 2012. The ECS questionnaire measures perceived self-efficacy for regular physical activity. It has two dimensions in the Exercise Confidence Survey: "sticking to it" and "making time for exercise". The survey has 8 questions to be answered by "I Know I can" (1 point) "Maybe I can" (3 points) or "I Know I cannot" (5 points). (Sallis et al., 1996)
    Time Frame
    Month 6
    Title
    Mediterranean diet adherence test in the Experimental Group
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 0
    Title
    Mediterranean diet adherence test in the Experimental Group
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 3
    Title
    Mediterranean diet adherence test in the Experimental Group
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 6
    Title
    Mediterranean diet adherence test in Controls
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 0
    Title
    Mediterranean diet adherence test in Controls
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 3
    Title
    Mediterranean diet adherence test in Controls
    Description
    The MEDAS (Mediterranean diet Adherence Screener) score is a 14-point self-administered questionnaire used to assess adherence to a Mediterranean diet, based on consumption thresholds for 11 food groups (olive oil, vegetables, fruit, red meat, butter or cream, sweetened beverages, wine, legumes, fish, pastries and nuts), plus an additional question on preferential consumption of red or white meat. A score of 9 or over proves adherence to the Mediterranean diet.
    Time Frame
    Month 6
    Title
    Understanding barriers to motivation: Experimental group
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 0
    Title
    Understanding barriers to motivation: Experimental group
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 3
    Title
    Understanding barriers to motivation: Experimental group
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 6
    Title
    Understanding barriers to motivation in Controls
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 0
    Title
    Understanding barriers to motivation in Controls
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 3
    Title
    Understanding barriers to motivation in Controls
    Description
    The main barriers to physical activity cited by patients, and the responses provided by the healthcare professional - peer helper as part of therapeutic education sessions will be identified. Qualitative research
    Time Frame
    Month 6

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient of legal age (≥ 18 years). Patient having undergone phase 2 treatment in the cardiovascular rehabilitation department of the CHU for myocardial infarction. Patient with a means of communication that allows easy internet connection (i.e. a smartphone). Patient fluent in French. Patient who has given free informed consent. Patient affiliated or beneficiary of a health insurance scheme. Exclusion Criteria: Patient with severe or unstable comorbidity (respiratory insufficiency renal failure, decompensated heart failure). heart failure). Patient with unstable angina. Patient with contraindications to physical activity following physical activity following cardiovascular rehabilitation (according to medical discussion, based on the recommendations of the French Society of Cardiology). Patient with no suitable means of communication. Patient under court protection, guardianship or curatorship. Pregnant, parturient or breast-feeding patients.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Alexis HOMS, Dr.
    Phone
    +334.66.68.34.59
    Email
    alexis.homs@chu-nimes.fr
    First Name & Middle Initial & Last Name or Official Title & Degree
    Anissa MEGZARI
    Phone
    +33466684236
    Email
    drc@chu-nimes.fr
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Virginie VALLAYER
    Organizational Affiliation
    Nîmes University Hospital
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Impact on Physical Activity of Coronary Patients in Phase 3 of a Therapeutic Consolidation Educational Program Involving a "Patient Partner" Associated With a Healthcare Professional.

    We'll reach out to this number within 24 hrs